Nu Skin Enterprises, Inc. (NUS) is a Consumer Discretionary stock trading at $4.74 (as of 2026-08-21), with a market capitalization of $230.73M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Nu Skin develops and distributes beauty and wellness products, including skin care systems and nutritional supplements, and it sells through its core network measured by customers, paid affiliates, and sales leaders.
Nu Skin’s profit model is tied to scaling its affiliate-led customer base (Customers, Paid Affiliates, Sales Leaders), which drives sales of its beauty and wellness products, alongside revenue contributions labeled as Rhyz and RISE.
| Americas | $0.1B |
| SE Asia/Pacific | $0.1B |
| Mainland China | $0.1B |
| South Korea | $0.1B |
Business quality (Weak): The most decision useful operating signals provided are customer and affiliate counts, while current profitability is thin (operating margin is much lower than gross margin).
Valuation: At 5× earnings, NUS trades 80% below the Wholesale average (24×). Note: one-time items can distort reported P/E.
| Price | $4.74 |
| Market Cap | $230.73M |
| EV / EBITDA | 6.4 |
| Price / Book | 0.43 |
| Price / Sales | 0.17 |
| FCF Yield | 4.7% |
| DCF Value (model) | $12.36 |
| DCF Upside vs Price | 160.8% |
| Revenue (TTM) | $1.49B |
| Net Margin | 10.8% |
| Revenue Growth (YoY) | -17.1% |
| EPS Growth (YoY) | -1295.3% |
| FCF Growth (YoY) | -86.1% |
| Altman Z-Score | 3.54 (safe) |
| Piotroski F-Score | 7/9 (strong) |
| Sector P/E (Consumer Discretionary) | 20.7 |
| Industry P/E (Wholesale) | 24.0 |
| Top Institutional Holder | BlackRock Fund Advisors ($204.03M) |
| Institutional Holders Tracked | 10 |
| Sector | Consumer Discretionary |
| Industry | Wholesale |
| CEO | Ryan S. Napierski |
| Employees | 3,100 |
| Country | US |
| IPO Date | 1996-11-22 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.